Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? (Q90312722)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

title

Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

inflammatory bowel diseases

12 April 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

author name string

Caroline Andrews

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

Daniel Paul Brice

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

Scott Kenneth Durum

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

Mairi Hall McLean

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

publication date

1 September 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

12 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

page(s)

2123-2134

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

Phenotypically distinct subsets of CD4 T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice

12 April 2020

cites work

1 reference

12 December 2020

CD4 T cells that express high levels of CD45RB induce wasting disease when transferred into congenic severe combined immunodeficient mice. Disease development is prevented by cotransfer of purified CD4 T cells

1 reference

12 December 2020

Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease

1 reference

12 December 2020

CD4 CD25 T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms

1 reference

12 December 2020

Cutting edge: cure of colitis by CD4 CD25 regulatory T cells

1 reference

12 December 2020

Role of cannabinoid CB1 receptors and tumor necrosis factor-alpha in the gut and systemic anti-inflammatory activity of SR 141716 (rimonabant) in rodents

1 reference

12 December 2020

Differential expression of homing receptor CD103 on lamina propria lymphocytes and association of CD103 with epithelial adhesion molecules in inflammatory bowel disease

1 reference

12 December 2020

A Failure of Transforming Growth Factor-β1 Negative Regulation Maintains Sustained NF-κB Activation in Gut Inflammation

1 reference

12 December 2020

Oral immune regulation using colitis extracted proteins for treatment of Crohn's disease: results of a phase I clinical trial

1 reference

12 December 2020

Peripheral and intestinal regulatory CD4 CD25(high) T cells in inflammatory bowel disease.

1 reference

12 December 2020

Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing

1 reference

12 December 2020

Identification and functional characterization of brainstem cannabinoid CB2 receptors

1 reference

12 December 2020

Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation

1 reference

12 December 2020

A double-blind clinical trial for treatment of Crohn's disease by oral administration of Alequel, a mixture of autologous colon-extracted proteins: a patient-tailored approach.

1 reference

12 December 2020

Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium

1 reference

12 December 2020

Functional CD4 CD25high regulatory T cells are enriched in the colonic mucosa of patients with active ulcerative colitis and increase with disease activity

1 reference

12 December 2020

NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

1 reference

12 December 2020

Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide

1 reference

12 December 2020

Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells

1 reference

12 December 2020

Expression and functional characterization of FOXP3 CD4 regulatory T cells in ulcerative colitis

1 reference

12 December 2020

Exacerbation of ulcerative colitis after rituximab salvage therapy

1 reference

12 December 2020

A functionally specialized population of mucosal CD103 DCs induces Foxp3 regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism

1 reference

12 December 2020

A phase I study of visilizumab, a humanized anti-CD3 monoclonal antibody, in severe steroid-refractory ulcerative colitis

1 reference

12 December 2020

Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system

1 reference

12 December 2020

Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors

1 reference

12 December 2020

Bifidobacterium infantis suppresses proinflammatory interleukin-17 production in murine splenocytes and dextran sodium sulfate-induced intestinal inflammation

1 reference

12 December 2020

Role of mucosal dendritic cells in inflammatory bowel disease

1 reference

12 December 2020

Cytotoxic-T-lymphocyte-associated antigen 4 blockade abrogates protection by regulatory T cells in a mouse model of microbially induced innate immune-driven colitis

1 reference

12 December 2020

MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha

1 reference

12 December 2020

Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells

1 reference

12 December 2020

Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.

1 reference

12 December 2020

IL-27 regulates homeostasis of the intestinal CD4 effector T cell pool and limits intestinal inflammation in a murine model of colitis

1 reference

12 December 2020

Prospective randomized open-label multicenter phase I/II dose escalation trial of visilizumab (HuM291) in severe steroid-refractory ulcerative colitis

1 reference

12 December 2020

Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis.

1 reference

12 December 2020

Intestinal inflammation abrogates the tolerogenic properties of MLN CD103 dendritic cells.

1 reference

12 December 2020

Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohnʼs disease†

1 reference

12 December 2020

Identification of microRNAs associated with ileal and colonic Crohn's disease

1 reference

12 December 2020

IL-37 is a fundamental inhibitor of innate immunity

1 reference

12 December 2020

Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis

1 reference

12 December 2020

IL-35-mediated induction of a potent regulatory T cell population.

1 reference

12 December 2020

Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17-producing T helper cells

1 reference

12 December 2020

Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species

1 reference

12 December 2020

Guidelines for the management of inflammatory bowel disease in adults

1 reference

12 December 2020

The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.

1 reference

12 December 2020

Role of miR‐150‐targeting c‐Myb in colonic epithelial disruption during dextran sulphate sodium‐induced murine experimental colitis and human ulcerative colitis

1 reference

12 December 2020

Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis.

1 reference

12 December 2020

Loss of Interleukin-10 or Transforming Growth Factor β Signaling in the Human Colon Initiates a T-Helper 1 Response Via Distinct Pathways

1 reference

12 December 2020

Interleukin 37 expression protects mice from colitis

1 reference

12 December 2020

Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis

1 reference

12 December 2020

Dendritic cells produce TSLP that limits the differentiation of Th17 cells, fosters Treg development, and protects against colitis

1 reference

12 December 2020

Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease

1 reference

12 December 2020

Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4 CD25- T cells

1 reference

12 December 2020

Interleukin 23 production by intestinal CD103( )CD11b( ) dendritic cells in response to bacterial flagellin enhances mucosal innate immune defense.

1 reference

12 December 2020

Lymphoid microenvironments and innate lymphoid cells in the gut.

1 reference

12 December 2020

An oral CD3-specific antibody suppresses T-cell-induced colitis and alters cytokine responses to T-cell activation in mice

1 reference

12 December 2020

Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease

1 reference

12 December 2020

Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice

1 reference

12 December 2020

Innate lymphoid cells--a proposal for uniform nomenclature

1 reference

12 December 2020

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease

1 reference

12 December 2020

Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells

1 reference

12 December 2020

Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model

1 reference

12 December 2020

Epithelial expression of interleukin-37b in inflammatory bowel disease

1 reference

12 December 2020

Associations between genetic polymorphisms in IL-33, IL1R1 and risk for inflammatory bowel disease

1 reference

12 December 2020

Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study

1 reference

12 December 2020

Retinoic acid expression associates with enhanced IL-22 production by γδ T cells and innate lymphoid cells and attenuation of intestinal inflammation.

1 reference

12 December 2020

Immunomodulation by Bifidobacterium infantis 35624 in the murine lamina propria requires retinoic acid-dependent and independent mechanisms

1 reference

12 December 2020

Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability

1 reference

12 December 2020

Why interleukin-10 supplementation does not work in Crohn's disease patients.

1 reference

12 December 2020

Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora.

1 reference

12 December 2020

miR-141 Regulates colonic leukocytic trafficking by targeting CXCL12β during murine colitis and human Crohn's disease

1 reference

12 December 2020

Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation

1 reference

12 December 2020

New targets for mucosal healing and therapy in inflammatory bowel diseases

1 reference

12 December 2020

NOD2-nitric oxide-responsive microRNA-146a activates Sonic hedgehog signaling to orchestrate inflammatory responses in murine model of inflammatory bowel disease

1 reference

12 December 2020

Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice

1 reference

12 December 2020

IL-27, targeting antigen-presenting cells, promotes Th17 differentiation and colitis in mice.

1 reference

12 December 2020

NOD2 expression is regulated by microRNAs in colonic epithelial HCT116 cells

1 reference

12 December 2020

TGF-β activation and function in immunity

1 reference

12 December 2020

NOD proteins: regulators of inflammation in health and disease

1 reference

12 December 2020

IL-10-producing regulatory B cells induced by IL-33 (Breg(IL-33)) effectively attenuate mucosal inflammatory responses in the gut.

1 reference

12 December 2020

Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium

1 reference

12 December 2020

Rectal microRNAs are perturbed in pediatric inflammatory bowel disease of the colon.

1 reference

12 December 2020

Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells

1 reference

12 December 2020

Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease.

1 reference

12 December 2020

The alarmin IL-33 promotes regulatory T-cell function in the intestine

1 reference

12 December 2020

Enteric glial cells and their role in the intestinal epithelial barrier

1 reference

12 December 2020

The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease

1 reference

12 December 2020

Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptors

1 reference

12 December 2020

miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD

1 reference

12 December 2020

The biology of innate lymphoid cells

1 reference

12 December 2020

Developing in vitro expanded CD45RA regulatory T cells as an adoptive cell therapy for Crohn's disease

1 reference

12 December 2020

Epidemiology and risk factors for IBD.

1 reference

12 December 2020

Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease

1 reference

12 December 2020

Harnessing regulatory T cells for the treatment of inflammatory bowel disease.

1 reference

12 December 2020

T regulatory cells and B cells cooperate to form a regulatory loop that maintains gut homeostasis and suppresses dextran sulfate sodium-induced colitis

1 reference

12 December 2020

Regulatory B cells: origin, phenotype, and function.

1 reference

12 December 2020

Interleukin-35: Expanding Its Job Profile

1 reference

12 December 2020

The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD.

1 reference

12 December 2020

Oral mixture of autologous colon-extracted proteins for the Crohn's disease: A double-blind trial

1 reference

12 December 2020

An IL-27/Lag3 axis enhances Foxp3 regulatory T cell-suppressive function and therapeutic efficacy.

1 reference

12 December 2020

Resident bacteria-stimulated IL-10-secreting B cells ameliorate T cell-mediated colitis by inducing Tr-1 cells that require IL-27-signaling

1 reference

12 December 2020

How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology

1 reference

12 December 2020

Interleukin 35 (IL-35) and IL-37: Intestinal and peripheral expression by T and B regulatory cells in patients with Inflammatory Bowel Disease

1 reference

12 December 2020

IL-37b gene transfer enhances the therapeutic efficacy of mesenchumal stromal cells in DSS-induced colitis mice

1 reference

12 December 2020

Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

1 reference

12 December 2020

Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn's Disease: A Phase I Study

1 reference

12 December 2020

miR-301a promotes intestinal mucosal inflammation through induction of IL-17A and TNF-α in IBD.

1 reference

12 December 2020

IL-33 alleviates DSS-induced chronic colitis in C57BL/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response.

1 reference

12 December 2020

Role of Dendritic Cells in the Induction of Lymphocyte Tolerance

1 reference

12 December 2020

Treatment of dextran sodium sulfate-induced experimental colitis by adoptive transfer of peritoneal cells.

1 reference

12 December 2020

Interleukin 33 is a guardian of barriers and a local alarmin

1 reference

12 December 2020

Role of regulatory T cell in the pathogenesis of inflammatory bowel disease

1 reference

12 December 2020

Oral immune therapy: targeting the systemic immune system via the gut immune system for the treatment of inflammatory bowel disease

1 reference

12 December 2020

IL-33 Drives Eosinophil Infiltration and Pathogenic Type 2 Helper T-Cell Immune Responses Leading to Chronic Experimental Ileitis.

1 reference

12 December 2020

Therapeutic anti-CD3 monoclonal antibodies: from bench to bedside

1 reference

12 December 2020

Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis

1 reference

12 December 2020

Interleukin 27 is up-regulated in patients with active inflammatory bowel disease

1 reference

12 December 2020

Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature

1 reference

12 December 2020

Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis.

1 reference

12 December 2020

Butyrate inhibits interleukin-17 and generates Tregs to ameliorate colorectal colitis in rats

1 reference

12 December 2020

Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution

1 reference

12 December 2020

Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial.

1 reference

12 December 2020

IL-33 regulates the IgA-microbiota axis to restrain IL-1α-dependent colitis and tumorigenesis

1 reference

12 December 2020

Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn's Disease, a Randomized Controlled Trial.

1 reference

12 December 2020

VEN-120, a recombinant human lactoferrin, promotes a regulatory T cell (Treg) phenotype and drives resolution of inflammation in distinct murine models of inflammatory bowel disease

1 reference

12 December 2020

Effects of Mongersen (GED-0301) on Endoscopic and Clinical Outcomes in Patients With Active Crohn's Disease.

1 reference

12 December 2020

Cathelicidin modulates synthesis of Toll-like Receptors (TLRs) 4 and 9 in colonic epithelium

1 reference

12 December 2020

Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses

1 reference

12 December 2020

Identifiers

DOI

10.1093/IBD/IZY230

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30020451 AND SRC:MED&resulttype=core&format=json

12 April 2020

PubMed publication ID

30020451

1 reference